Facebook Linkedin RSS Twitter Youtube
Home 2025

Endocrine diseases

Mass Migration of Immune Cells Found to Regulate Blood Glucose Levels
Featured

Mass Migration of Immune Cells Found to Regulate Blood Glucose Levels

Iconovo and Lonza Agree to Collaborate on the Formulation Development of an Intranasal Biologic
Bioprocessing

Iconovo and Lonza Agree to Collaborate on the Formulation Development of an Intranasal Biologic

Potential New Obesity Target Found in Mitochondrial Protein Involved in Brown Fat Thermogenesis
Featured

Potential New Obesity Target Found in Mitochondrial Protein Involved in Brown Fat Thermogenesis

Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration
Artificial Intelligence

Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

StockWatch: Wall Street’s Leaders and Laggards of 2024
GEN Edge

StockWatch: Wall Street’s Leaders and Laggards of 2024

Uncovering Craniopharyngioma’s Growth Mechanism May Identify New Therapy
News

Uncovering Craniopharyngioma’s Growth Mechanism May Identify New Therapy

Targeting a Brain Enzyme May Be the Key to Unlocking New Obesity Strategies
News

Targeting a Brain Enzyme May Be the Key to Unlocking New Obesity Strategies

Locally Immunoprotective Synthetic Suppressor T Cells Could Reduce Need for Systemic Immunosuppression
Featured

Locally Immunoprotective Synthetic Suppressor T Cells Could Reduce Need for Systemic Immunosuppression

Amgen Raises NC Investment to $1.5B with Plans for Second Plant
Bioprocessing

Amgen Raises NC Investment to $1.5B with Plans for Second Plant

Force of Nature: Enveda Raises $130M, Advances Lead Pipeline Candidate
Artificial Intelligence

Force of Nature: Enveda Raises $130M, Advances Lead Pipeline Candidate

123...209Page 1 of 209
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.